Back to search results

A Microdose Trial Investigating Binding of [68Ga]Ga-DOTA-CYS-ATH001 in Healthy Subjects and Different Patient Groups.

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

MASH · PSC · Fibrostenotic Crohn's Disease · Healthy Volunteers

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • CTC Karolinska, Stockholm, Sweden

    Contact: Study coordinator (Kaveh Azizi, MD) · kaveh.azizi@ctc-ab.se · +46 (0)76 140 56 21
    Contact: Principal Investigator (Kaveh Azizi, MD)

  • CTC Akademiska Uppsala University Hospital, Entrance 85, 2nd level, Uppsala, Sweden

    Contact: Study coordinator (Erik Rein-Hedin, MD) · erik.rein-hedin@ctc-ab.se · +46 (0)70 755 20 89
    Contact: Principal Investigator (Erik Rein-Hedin, MD)

  • Section of Gastroenterology/Hepatology, Uppsala University Hospital, Uppsala, Sweden

    Contact: Study coordinator (Johan Vessby, MD, PhD) · johan.vessby@akademiska.se · +46 (0)73 356 93 04
    Fredrik Rorsman, MD, PhD (Sub-investigator)
    Eva-Lena Syren, MD (Sub-investigator)
    Kajsa Björner, MD (Sub-investigator)
    Contact: Principal Investigator (Johan Vessby, MD, Phd)
Study leads

  • Johan Vessby

    Principal Investigator

    Section of Gastroenterology/Hepatology SE-751 85 Uppsala, Sweden

View source on ClinicalTrials.gov(opens in a new tab)